- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Video
What's Up and Coming in MCC
Author(s):
In this fourth part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, talks about what to look forward to in treatment and clinical trials of merkel cell carcinoma (MCC).
Video Player is loading.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care
One-Stop Shop: RAD Offers Comprehensive Insights Into AD Diagnosis, Treatment, and Research
Apoptosis-Based Skin Cancer Treatment Shows Promise
Mastering Dermoscopy and Dysplastic Nevi
Improving Acne Treatment Through Antibiotic Stewardship and Gut-Skin Health
Addressing Ongoing Benzoyl Peroxide and Benzene Updates at AAD 2025
Reviewing 3 Key Lebrikizumab Abstracts From AAD 2025
Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters
How to Avoid Complications With Radiofrequency and Ultrasound-Based Technologies
Michael Gold, MD: Insights on Silicone, Energy-Based Devices, and Radiation Therapy
Related Content
